GlassScriptPhysician profile
Melissa A Friedman
NPI 1174510820
$311.70
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $177 · 2020: $59.08 · 2021: $75.22.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $102.62 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $35.19 | 2019-2020 | |
| Mallinckrodt Enterprises LLC | $25.81 | 2019 | |
| Avion Pharmaceuticals | $24.66 | 2019-2020 | |
| Vertical Pharmaceuticals, LLC | $19.28 | 2019 | |
| Amag Pharmaceuticals, INC. | $18.11 | 2019 | |
| Duchesnay USA Incorporated | $17.07 | 2019 | |
| Pfizer INC. | $15.33 | 2021 | |
| Allergan, INC. | $14.53 | 2019 | |
| Hologic Sales and Service, LLC | $14.01 | 2019 | |
| Therapeuticsmd, INC. | $13.45 | 2019 | |
| Coopersurgical, INC. | $11.64 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Friedman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.